A Massachusetts man is the only one in the country who has tried a nasal spray treatment for Alzheimer's. He's going to help ...

The neffyinSchools program from ARS Pharma will provide eligible public and private K-12 schools in the United States with ...

Nasal vaccine devices have the potential to offer more convenient and more effective protection against a variety of viruses.

The kits include two Narcan nasal spray devices with instructions for the proper administration and steps to be taken in the ...

Milestone Pharmaceuticals (MIST) announced that it has received Notice of Allowance from the United States Patent and Trademark Office, or ...

Compared with placebo, zavegepant nasal spray yielded sustained relief of acute pain and function in migraine.

Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

The Prescription Drug User Fee Act (PDUFA) date refers to the deadline set by the US Food and Drug Administration (FDA) for reviewing a New Drug Application (NDA) or Biologics License Application (BLA ...

My first experience of hay fever was when I was revising for my A-level exams over thirty years ago,” Catherine said. “That ...

Letters to the editors for the November 2024 issue of Scientific American ...

Many recalls come as a result of product mislabeling, safety issues or contamination. Here are five recalls in particular ...